The off-patent medicines industry is a cornerstone of European healthcare, accounting for 70% of medicines dispensed in Europe. These drugs treat a range of severe conditions, including cancer, respiratory diseases, and autoimmune disorders, forming an essential part of health systems. However, the significant economic and health impact of the off-patent medicines industry comes with great Continue reading “Balancing Sustainability and Access: The Future of Off-Patent Medicines”
Resource Category Archives
Healthy patients, healthy planet: tackling the carbon footprint of clinical trials
The Sustainable Healthcare Coalition is developing a tool to track carbon emissions from clinical trials and our Chair, Dr Fiona Adshead spoke to Clinical Trials Arena about the project. While the healthcare industry is responsible for saving millions of human lives, its work comes at a considerable cost to the environment. The healthcare industry accounts for Continue reading “Healthy patients, healthy planet: tackling the carbon footprint of clinical trials”